Genedrive (GDR) RNS Announcements

Add to Alert list
Date Time Source Announcement
17 Jan 2018 07:00 AM
RNS
Trading update
16 Jan 2018 07:00 AM
RNS
First Successful Field Evaluation of HCV Assay
13 Dec 2017 07:15 AM
RNS
Hardman Research: Remodelled for growth
07 Dec 2017 04:28 PM
RNS
Director/PDMR Shareholding
29 Nov 2017 02:19 PM
RNS
Result of AGM
21 Nov 2017 07:00 AM
RNS
genedrive plc awarded Innovate UK grant
17 Nov 2017 11:25 AM
RNS
2017 Annual Report and AGM Notice
14 Nov 2017 07:00 AM
RNS
Distribution agreement with Sysmex Asia Pacific
08 Nov 2017 01:31 PM
RNS
Directorate Change
06 Nov 2017 08:51 AM
RNS
Holding(s) in Company
02 Nov 2017 07:00 AM
RNS
Distribution update for India
23 Oct 2017 07:00 AM
RNS
Launches Genedrive® Hepatitis C test in Africa
18 Oct 2017 07:00 AM
RNS
Holding(s) in Company
17 Oct 2017 07:00 AM
RNS
Preliminary Results
16 Oct 2017 07:00 AM
RNS
Distribution Agreement
11 Oct 2017 07:00 AM
RNS
Notice of Preliminary Results
22 Sep 2017 09:42 AM
RNS
Holding(s) in Company
11 Sep 2017 07:00 AM
RNS
Genedrive HCV Kit received CE Marking
27 Jul 2017 07:00 AM
RNS
$1.4m Funding from US Department of Defense
13 Jul 2017 07:00 AM
RNS
Trading Update
11 Apr 2017 07:00 AM
RNS
Hep C data presentation at EASL
05 Apr 2017 12:39 PM
RNS
Director/PDMR Shareholding - Replacement
05 Apr 2017 11:17 AM
RNS
Director/PDMR Shareholding
30 Mar 2017 07:00 AM
RNS
Interim Results
27 Mar 2017 07:00 AM
RNS
HCV Assay submitted for CE IVD Certification
24 Mar 2017 07:00 AM
RNS
Notice of Interim Results
08 Mar 2017 07:00 AM
RNS
Successful Clinical Results - Genedrive HCV Assay
20 Feb 2017 07:00 AM
RNS
Director/PDMR Shareholding
06 Feb 2017 05:53 PM
RNS
Holdings in Company
27 Jan 2017 07:00 AM
RNS
Trading Update
16 Jan 2017 07:00 AM
RNS
Update on US Department of Defense Programme
23 Dec 2016 10:48 AM
RNS
Director/PDMR Shareholding
30 Nov 2016 02:16 PM
RNS
Result of AGM
29 Nov 2016 07:00 AM
RNS
Update on CFO Appointment
17 Nov 2016 07:00 AM
RNS
CE-IVD Certification for Human Genotyping Test
11 Nov 2016 05:47 PM
RNS
Notice of AGM
11 Oct 2016 07:00 AM
RNS
Preliminary Results for the year end 30 June 2016
21 Sep 2016 07:00 AM
RNS
Notice of Preliminary Results
21 Sep 2016 07:00 AM
RNS
Appointment of Chief Financial Officer
10 Aug 2016 07:00 AM
RNS
Genedrive Assay used in STOP-HCV-1 Clinical Trial
02 Aug 2016 07:00 AM
RNS
Trading Update
29 Jul 2016 05:58 PM
RNS
Total Voting Rights
25 Jul 2016 07:00 AM
RNS
Re change of name, TIDM and website address
14 Jul 2016 03:56 PM
RNS
Holding(s) in Company
14 Jul 2016 08:19 AM
RNS
Director/PDMR Shareholding
14 Jul 2016 08:18 AM
RNS
Holding(s) in Company
13 Jul 2016 02:49 PM
RNS
Holding(s) in Company
12 Jul 2016 09:05 AM
RNS
Director/PDMR Shareholding
11 Jul 2016 11:34 AM
RNS
Result of General Meeting and Change of Name
23 Jun 2016 04:54 PM
RNS
Posting of Shareholder Circular

Genedrive plc is a medical equipment company based in Manchester, UK that develops and sells point-of-care molecular diagnostic platforms. Their products are used in healthcare settings, particularly in emergency medicine, for patient stratification and disease detection. Genedrive's goal is to improve clinical outcomes with easy-to-use tests. 

 Genedrive's major products include:
Genedrive CYP2C19 ID Kit: A rapid test that establishes metaboliser status in time-critical settings
Genedrive MT-RNR1 ID Kit: The world's first point-of-care genetic test to reduce the risk of aminoglycoside induced hearing loss

Genedrive was founded on contract research services for pharmaceutical and biotech companies, and was originally named Epistem Holdings Inc. when it was floated on the London AIM market in 2007. The company was renamed genedrive plc in 2016 to reflect its new focus on molecular diagnostics, and divested its contract research services divisions in 2018.

GDR share price launched at 129p in 2007. 

UK 100

Latest directors dealings